318 related articles for article (PubMed ID: 20113168)
1. Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: formulation, characterization and in vivo evaluation.
Sun S; Liang N; Piao H; Yamamoto H; Kawashima Y; Cui F
J Microencapsul; 2010; 27(6):471-8. PubMed ID: 20113168
[TBL] [Abstract][Full Text] [Related]
2. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
[TBL] [Abstract][Full Text] [Related]
3. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
Kumar PS; Ramakrishna S; Saini TR; Diwan PV
Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
[TBL] [Abstract][Full Text] [Related]
4. Multi-arm histidine copolymer for controlled release of insulin from poly(lactide-co-glycolide) microsphere.
Park W; Kim D; Kang HC; Bae YH; Na K
Biomaterials; 2012 Dec; 33(34):8848-57. PubMed ID: 22959184
[TBL] [Abstract][Full Text] [Related]
5. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.
Wu ZM; Zhou L; Guo XD; Jiang W; Ling L; Qian Y; Luo KQ; Zhang LJ
Int J Pharm; 2012 Apr; 425(1-2):1-8. PubMed ID: 22248666
[TBL] [Abstract][Full Text] [Related]
6. Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin.
Jain S; Rathi VV; Jain AK; Das M; Godugu C
Nanomedicine (Lond); 2012 Sep; 7(9):1311-37. PubMed ID: 22583576
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization and in vivo evaluation of pH-sensitive oral insulin-loaded poly(lactic-co-glycolicacid) nanoparticles.
Yang J; Sun H; Song C
Diabetes Obes Metab; 2012 Apr; 14(4):358-64. PubMed ID: 22151795
[TBL] [Abstract][Full Text] [Related]
8. Optimized preparation of insulin-lauryl sulfate complex loaded poly (lactide-co-glycolide) nanoparticles using response surface methodology.
Shi K; Cui F; Yamamoto H; Kawashima Y
Pharmazie; 2008 Oct; 63(10):721-5. PubMed ID: 18972833
[TBL] [Abstract][Full Text] [Related]
9. In vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticles.
Reix N; Parat A; Seyfritz E; Van der Werf R; Epure V; Ebel N; Danicher L; Marchioni E; Jeandidier N; Pinget M; Frère Y; Sigrist S
Int J Pharm; 2012 Nov; 437(1-2):213-20. PubMed ID: 22940208
[TBL] [Abstract][Full Text] [Related]
10. Investigation of drug loading and in vitro release mechanisms of insulin-lauryl sulfate complex loaded PLGA nanoparticles.
Shi K; Cui F; Yamamoto H; Kawashima Y
Pharmazie; 2008 Dec; 63(12):866-71. PubMed ID: 19177901
[TBL] [Abstract][Full Text] [Related]
11. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
[TBL] [Abstract][Full Text] [Related]
12. Antacid co-encapsulated polyester nanoparticles for peroral delivery of insulin: development, pharmacokinetics, biodistribution and pharmacodynamics.
Sharma G; van der Walle CF; Ravi Kumar MN
Int J Pharm; 2013 Jan; 440(1):99-110. PubMed ID: 22227604
[TBL] [Abstract][Full Text] [Related]
13. Insulin nanoparticle preparation and encapsulation into poly(lactic-co-glycolic acid) microspheres by using an anhydrous system.
Han Y; Tian H; He P; Chen X; Jing X
Int J Pharm; 2009 Aug; 378(1-2):159-66. PubMed ID: 19465100
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional Composite Microcapsules for Oral Delivery of Insulin.
Sun S; Liang N; Gong X; An W; Kawashima Y; Cui F; Yan P
Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28036045
[TBL] [Abstract][Full Text] [Related]
15. Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation.
Cui F; Shi K; Zhang L; Tao A; Kawashima Y
J Control Release; 2006 Aug; 114(2):242-50. PubMed ID: 16859800
[TBL] [Abstract][Full Text] [Related]
16. Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery.
Cui FD; Tao AJ; Cun DM; Zhang LQ; Shi K
J Pharm Sci; 2007 Feb; 96(2):421-7. PubMed ID: 17051590
[TBL] [Abstract][Full Text] [Related]
17. Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles.
Xie S; Wang S; Zhao B; Han C; Wang M; Zhou W
Colloids Surf B Biointerfaces; 2008 Dec; 67(2):199-204. PubMed ID: 18829272
[TBL] [Abstract][Full Text] [Related]
18. In vitro release and stereoselective disposition of flurbiprofen loaded to poly(D,L-lactide- co-glycolide) nanoparticles in rats.
Radwan MA; Aboul-Enein HY
Chirality; 2004 Feb; 16(2):119-25. PubMed ID: 14712475
[TBL] [Abstract][Full Text] [Related]
19. Effect of poly(ethylene glycol) content and formulation parameters on particulate properties and intraperitoneal delivery of insulin from PLGA nanoparticles prepared using the double-emulsion evaporation procedure.
Haggag YA; Faheem AM; Tambuwala MM; Osman MA; El-Gizawy SA; O'Hagan B; Irwin N; McCarron PA
Pharm Dev Technol; 2018 Apr; 23(4):370-381. PubMed ID: 28285551
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of controlled release insulin loaded PLGA microcapsules using dry powder inhaler in diabetic rats.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Hassanzadeh K; Mahdavi H; Koohsoltani M; Nokhodchi A
Biopharm Drug Dispos; 2010 Mar; 31(2-3):189-201. PubMed ID: 20238376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
